Risk factors for radiation maculopathy and papillopathy after intraocular irradiation

Ophthalmology

Volumn 106, Issue 8, 1999, Pages 1571-1578

  Gragoudas, Evangelos S ^a   Li, Wenjun ^a   Lane, Anne Marie ^a   Munzenrider, John ^b   Egan, Kathleen M ^a,c  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOROID MELANOMA; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION SICKNESS; RETINA MACULOPATHY; RISK FACTOR; VISUAL IMPAIRMENT;

EID: 0033492554     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90455-4     Document Type: Article

References (34)

1. Mukai S, Guyer DR, Gragoudas ES. Radiation retinopathy. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology: Clinical Practice. Philadelphia: W. B. Saunders, 1994; 1038-41.
2. Seddon JM, Gragoudas ES, Egan KM, et al. Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology 1987;94:354-61.
3. Guyer DR, Mukai S, Egan KM, et al. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 1992;99:1278-85.
4. Saornil MA, Egan KM, Gragoudas ES, et al. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol 1992;110:1112-8.
5. Gragoudas ES, Goitein M, Koehler AM, et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 1977;83:665-73.
6. Gragoudas E, Goitein M, Verhey L, et al. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch Ophthalmol 1982;100:928-34.
7. Gragoudas ES, Seddon J, Goitein M, et al. Current results of proton beam irradiation of uveal melanomas. Ophthalmology 1985;92:284-91.
8. Gragoudas ES, Seddon JM, Egan K, et al. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-53.
9. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457.
10. Cox D. Regression models and life-tables. J Roy Stat Soc Ser 1972;34:187.
11. Cleveland WAS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
12. StataCorp. Stata Statistical Software: Release 5.0. College Station, TX. Stata Corporation 1997;2:296.
13. Brown GC, Shields JA, Sanborn G, et al. Radiation optic neuropathy. Ophthalmology 1982;89:1489-93.
14. Hykin PG, Shields CL, Shields JA, Arevalo JF. The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 1998;105:1425-9.
15. Wara WM, Irvine AR, Neger RE, et al. Radiation retinopathy. Int J Radiat Oncol Biol Phys 1979;5:81-3.
16. Perrers-Taylor M, Brinkley D, Reynolds T. Choroido-retinal damage as a complication of radiotherapy. Acta Radiol Oncol 1965;3:431.
17. Chacko DC. Considerations in the diagnosis of radiation injury. JAMA 1981;245:1255-8.
18. Brown GC, Shields JA, Sanborn G, et al. Radiation retinopathy. Ophthalmology 1982;89:1494-501.
19. Dhir SP, Joshi AV, Banerjee AK. Radiation retinopathy in diabetes mellitus: report of a case. Acta Radiol Oncol 1982; 21:111-3.
20. Viebahn M, Barricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 1991;75:629-32.
21. Karren KA, Krou SM, Char DH, Castro JR. Diabetic radiation morbidity [letter]. Br J Ophthalmol 1992;76:61-2.
22. Rodier JF. Radiation enteropathy - incidence, aetiology, risk factors, pathology and symptoms. Tumori 1995;81(3 Suppl): 122-5.
23. Roeske JC, Mundt AJ, Halpern H, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. Int J Radiat Oncol Biol Phys 1997;37:351-8.
24. Schultheiss TE, Lee WR, Hunt MA, et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:3-11.
25. Hopewell JW. Radiation injury to the central nervous system [review]. Med Pediatr Oncol 1998;Suppl 1:1-9.
26. McMillan DE. Development of vascular complications in diabetes. Vasc Med 1997;2:132-42.
27. Baumann M. Is curative radiation therapy in elderly patients limited by increased normal tissue toxicity? Radiother Oncol 1998;46:225-7.
28. Gragoudas ES, Egan KM, Walsh SM, et al. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol 1995;119:157-64.
29. Lanciano RM, Martz K, Montana GS, Hanks GE. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix. A pattern of care study. Cancer 1992;69:2124-30.
30. Milas L, Hanson WR. Eicosanoids and radiation [review]. Eur J Cancer 1995;31A:1580-5.
31. Michalowski AS. Anti-inflammatory drug treatment of radiation injuries. Adv Exp Med Biol 1997;400B:873-7.
32. Hopewell J, van den Aardweg GJMJ, Morris G, et al. Unsaturated lipids as modulators of radiation damage to normal tissues. In: Horrobin DF, ed. New Approaches to Cancer Treatment. New York: Churchill Communications Europe, 1994: 88-106.
33. El-Agamawi AT, Hopewell JW, Plowman PN, et al. Modulation of normal tissue response to radiation [letter]. Br J Radiol 1996;69:374-5.
34. Hornsey S, Myers R, Jenkinson T. The reduction of radiation damage to the spinal chord by post-irradiation administration of vasoactive drugs. Int J Radiat Oncol Biol Phys 1990; 18:1437-42.